 SOUTH SAN FRANCISCO, Calif., Sept. 08, 2021 GLOBE NEWSWIRE -- Lyell Immunopharma, Inc. Lyell, Nasdaq: LYEL, a T cell reprogramming company dedicated to the mastery of T cells to cure patients with solid tumors, today announced that members of its senior management team will participate in a virtual fireside chat at the Morgan Stanley 19th Annual Global Healthcare Conference on Wednesday, September 15, at 2:00 PM ET. 